(Q38071074)

28 August 2017

1 reference

title

Non-Hodgkin lymphoma: the clinician's perspective--a view from the receiving end. (English)

1 reference

28 August 2017

1

Joseph M Connors

1 reference

28 August 2017

publication date

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

26 Suppl 1

1 reference

28 August 2017

page(s)

S111-8

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.184

28 August 2017

exact match

0 references

cites work

The clinical impact of expert pathological review on lymphoma management: a regional experience

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Importance of expert central review in the diagnosis of lymphoid malignancies in a regional cancer network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Hand-assisted laparoscopic splenectomy versus open splenectomy for massive splenomegaly: 20-year experience at a Canadian centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Outcome of deferred initial therapy in mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Crizotinib in anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Molecular diagnosis of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Adult Burkitt leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Transformation of indolent B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Popula

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Primary Central Nervous System Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Intraocular lymphoma. Clinical and histopathologic diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Double-hit B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

Clinical impact of pathology reviews of outside material: a patient-focused approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: Results of a 196-patient series

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Bl

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Testicular lymphoma: improved outcome with early brief chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Primary central nervous system lymphoma: treatment with chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Combined therapy for primary central nervous system lymphoma in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Radiotherapy is successful treatment for orbital lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Multiagent chemotherapy in the salvage cure of ocular lymphoma relapsing after radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.184

7 January 2021

10.1038/MODPATHOL.2012.184

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1043906435

0 references

1 reference